GCCL Hosts Clinical Sample Analysis (GCLP) Training in Collaboration with KSQA

Strengthening quality capabilities to deliver more reliable and consistent services

GCCL hosted the 2026 Clinical Sample Analysis (GCLP) Training on March 17, 2026, at Room R300, 3rd Floor, GC R&D Center, 

in collaboration with the Korean Society of Quality Assurance (KSQA). 

The program was organized for participants across the GC Group as part of GCCL’s ongoing efforts 

to reinforce quality standards and enhance operational excellence in clinical sample analysis.

As clinical trials become increasingly complex and expectations surrounding regulatory compliance, data reliability, and quality management continue to rise, 

organizations involved in clinical sample analysis are expected to maintain not only technical expertise but also a strong and consistent quality mindset. 

Against this backdrop, GCCL planned this training to provide a practical and meaningful learning opportunity for GC Group affiliates, 

with the goal of deepening understanding of GCLP principles and strengthening the overall quality of related operations.

The training program covered a range of key topics relevant to today’s clinical sample analysis environment. 

The session opened with welcoming remarks from Kwan Goo Cho, CEO of GCCL, 

followed by a presentation on GCLP preparation documents and record retention requirements. 

This session highlighted the importance of establishing and maintaining proper documentation practices 

in accordance with clinical trial sample analysis standards, 

emphasizing that robust document control is a fundamental part of quality-based laboratory operations.

The program also included a session on the latest GCLP trends, from chain of custody to data integrity, 

addressing areas that have become increasingly important in clinical sample analysis. 

As traceability, accountability, and reliable data handling continue to receive greater attention across the industry, 

the session offered practical insight into how these principles should be applied throughout the analytical process. 

In particular, it reinforced the idea that consistent quality is built not only on analytical performance itself, 

but also on the processes and systems that support every stage of sample handling and data management.

Another session focused on changes in the clinical trial environment and understanding sponsor expectations. 

As sponsor requirements become more sophisticated and project needs more specialized, 

laboratory service providers are increasingly expected to demonstrate not only technical capabilities, 

but also a clear understanding of client expectations, regulatory considerations, and study-specific quality demands. 

This part of the program provided participants with a broader perspective on 

how the clinical landscape is evolving and what that means for organizations supporting clinical development.

The final session addressed inspection readiness and response, offering practical guidance on how to prepare for and respond to inspections effectively. 

This topic was particularly meaningful in helping participants better understand the operational discipline and readiness required 

to support high-quality clinical sample analysis under real-world conditions.

More than a one-time educational event, this training served as a valuable opportunity to share knowledge, 

align on quality expectations, and reinforce a common understanding of best practices across the GC Group. 

By covering both foundational principles and current industry considerations, the program helped participants connect day-to-day laboratory 

and operational practices with the broader objective of maintaining high standards in clinical sample analysis.

For GCCL, initiatives such as this training reflect a broader commitment to continuous improvement. 

Delivering reliable and consistent services requires more than technical infrastructure alone; 

it also depends on strong documentation practices, regulatory awareness, inspection readiness, and a shared quality culture across the organization. 

Through this program, GCCL sought to further strengthen those capabilities and contribute to a more robust quality foundation for future operations.

GCCL believes that ongoing education and collaboration are essential to elevating overall service quality. 

By working together with organizations such as KSQA and engaging participants across the GC Group, 

GCCL aims to foster a culture of quality that supports not only internal capability building, but also better outcomes for partners and clients.

GCCL extends its sincere appreciation to KSQA, all speakers, and all participants 

who contributed to making this training a meaningful and productive session. 

Going forward, GCCL will continue to pursue opportunities for education, collaboration, and quality enhancement 

in order to provide dependable, high-quality clinical sample analysis services in a rapidly evolving clinical development environment.